Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours
Clinical trial NCT01859351 · TERMINATED
Trial details
- NCT number
- NCT01859351
- Sponsor
- Heidelberg Pharma AG
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-04-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.